Cargando…

Successful rechallenge with ceritinib after leukocytoclastic vasculitis during ceritinib treatment for non-small cell lung cancer harboring the EML4-ALK fusion protein

Anaplastic lymphoma kinase (ALK)-tyrosine kinase inhibitors (TKIs) dramatically improve progression-free survival compared to cytotoxic agents. It is therefore important to manage patients with ALK-TKIs until drug resistance occurs. Leukocytoclastic vasculitis (LCV) is a rare complication during can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okimoto, Tamio, Tsubata, Yukari, Hotta, Takamasa, Hamaguchi, Megumi, Okuno, Takae, Shiratsuki, Yohei, Kodama, Akari, Nakao, Mika, Amano, Yoshihiro, Hamaguchi, Shunichi, Kurimoto, Noriaki, Tobita, Reiko, Isobe, Takeshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929456/ https://www.ncbi.nlm.nih.gov/pubmed/29732013 http://dx.doi.org/10.18632/oncotarget.24765

Ejemplares similares

Acute Interstitial Lung Disease Induced by Rechallenge with Ceritinib
por: Hotta, Takamasa, et al.
Publicado: (2019)

Varicella-zoster Virus Related Pulmonary Granulomas in Which Varicella-zoster Virus DNA Was Demonstrated in a Thoracoscopic Lung Biopsy Specimen
por: Isobe, Takeshi, et al.
Publicado: (2019)

Ultra-magnifying Imaging of Thoracoscopic Biopsy Specimens Using Ex vivo Endocytoscopy in Three Patients with Mesothelioma
por: Shiratsuki, Yohei, et al.
Publicado: (2022)

Prospective clinical trial evaluating vulnerability and chemotherapy risk using geriatric assessment tools in older patients with lung cancer
por: Tsubata, Yukari, et al.
Publicado: (2019)

Usefulness of endocytoscopy in evaluating transbronchial biopsy specimens
por: Okuno, Takae, et al.
Publicado: (2022)

Deep learning-based diagnosis from endobronchial ultrasonography images of pulmonary lesions
por: Hotta, Takamasa, et al.
Publicado: (2022)

Use of saline to evaluate a cavity due to Mycobacterium kansasii infection during ultrathin bronchoscopy and endobronchial ultrasonography
por: Hamaguchi, Megumi, et al.
Publicado: (2021)

Comparative Analysis of the Attitudes toward Palliative Care between Medical Oncologists and Pulmonologists
por: Okimoto, Tamio, et al.
Publicado: (2021)

A Retrospective Study of Pneumococcal Pneumonia in Hospitalized Patients Aged ≥65 Years in Izumo, Japan: 2010 to 2014
por: Hamaguchi, Megumi, et al.
Publicado: (2023)

Exogenous lipoid pneumonia caused by herbicide inhalation
por: Hotta, Takamasa, et al.
Publicado: (2016)

Pleuroparenchymal fibroelastosis after haematopoietic stem cell transplantation without graft‐versus‐host disease findings
por: Okimoto, Tamio, et al.
Publicado: (2018)

A Low Crizotinib Concentration in the Cerebrospinal Fluid Causes Ineffective Treatment of Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer with Carcinomatous Meningitis
por: Okimoto, Tamio, et al.
Publicado: (2018)

Comparative postoperative outcomes of GGN-dominant vs single lesion lung adenocarcinomas
por: Hotta, Takamasa, et al.
Publicado: (2020)

Nontuberculous Mycobacterium‐associated immune reconstitution inflammatory syndrome in a non‐HIV immunosuppressed patient
por: Kobayashi, Misato, et al.
Publicado: (2022)

An endobronchial hamartoma observed using narrow band imaging under saline injection: A case report
por: Kobayashi, Misato, et al.
Publicado: (2022)

Acute Exacerbation of Tracheal Obstruction and Severe Respiratory Failure after a Single Dose of 2-Gy Irradiation for Squamous Cell Lung Carcinoma: A Case Report
por: Kawakado, Keita, et al.
Publicado: (2022)

The Association Between Cyclooxygenase-2 –1195G/A (rs689466) Gene Polymorphism and the Clinicopathology of Lung Cancer in the Japanese Population: A Case-Controlled Study
por: Sun , Rong, et al.
Publicado: (2022)

A Novel Model-Based Questionnaire Based on Low-Dose CT Screening Data for Chronic Obstructive Pulmonary Disease Diagnosis in Shimane, Japan
por: Tanino, Akari, et al.
Publicado: (2021)

Comparison of Ultra-Magnifying Endocytoscopic and Hematoxylin-Eosin-Stained Images of Lung Specimens
por: Kobayashi, Misato, et al.
Publicado: (2023)

Reproducible abscopal effect in a patient with lung cancer who underwent whole‐brain irradiation and atezolizumab administration
por: Hotta, Takamasa, et al.
Publicado: (2021)

Ceritinib for ALK-Rearrangement–Positive Non–Small Cell Lung Cancer
por: Nix, Nancy M., et al.
Publicado: (2015)

Spotlight on ceritinib in the treatment of ALK+ NSCLC: design, development and place in therapy
por: Santarpia, Mariacarmela, et al.
Publicado: (2017)

Safety and Activity of the Combination of Ceritinib and Dasatinib in Osteosarcoma
por: Beck, Olaf, et al.
Publicado: (2020)

Clinical Management of Asthma by Respiratory Specialists versus General Practitioners: Questionnaire Survey Results Over 6 Years
por: Hamaguchi, Megumi, et al.
Publicado: (2021)

Multiple Mass Lesions in Pneumocystis Pneumonia
por: Kobayashi, Misato, et al.
Publicado: (2022)

Immune‐related adverse events in hepatitis treated with thiopurine‐based immunosuppressants: A case report
por: Kawakado, Keita, et al.
Publicado: (2023)

Profile of ceritinib in the treatment of ALK+ metastatic non-small-cell lung cancer
por: Burns, Mark W, et al.
Publicado: (2015)

Targeting Anaplastic Lymphoma Kinase (ALK) in Rhabdomyosarcoma (RMS) with the Second-Generation ALK Inhibitor Ceritinib
por: van Erp, Anke E. M., et al.
Publicado: (2017)

Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma to the ALK inhibitor ceritinib
por: Guan, Jikui, et al.
Publicado: (2018)

Efficacy of erlotinib and its effects on the quality of life of older patients with epidermal growth factor receptor‐mutant non‐small cell lung cancer: A prospective, multicenter, dose‐modification study
por: Tsubata, Yukari, et al.
Publicado: (2021)

STRN-ALK Rearranged Malignant Peritoneal Mesothelioma With Dramatic Response Following Ceritinib Treatment
por: Rüschoff, Jan H., et al.
Publicado: (2019)

ALK Rearrangement Adenocarcinoma with Histological Transformation to Squamous Cell Carcinoma Resistant to Alectinib and Ceritinib
por: Kaiho, Taisuke, et al.
Publicado: (2020)

Pulmonary granulomatous inflammation after ceritinib treatment in advanced ALK-rearranged pulmonary adenocarcinoma
por: Liao, Juanyan, et al.
Publicado: (2022)

Antibiotic‐induced reduction of abnormal lung shadow in pulmonary nodular lymphoid hyperplasia
por: Tanino, Akari, et al.
Publicado: (2020)

The ALK inhibitors, alectinib and ceritinib, induce ALK‐independent and STAT3‐dependent glioblastoma cell death
por: Kawauchi, Daisuke, et al.
Publicado: (2021)

Organizing pneumonia in ALK+ lung adenocarcinoma treated with ceritinib: A case report and literature review
por: Wu, Yonghui, et al.
Publicado: (2021)

Neoadjuvant ceritinib treatment in ALK ‐rearranged locally advanced adenosquamous carcinoma: A case report
por: Mai, Shixiong, et al.
Publicado: (2022)

Ceritinib‐associated hyperglycemia in the Japanese Adverse Drug Event Report Database
por: Fujita, Haruka, et al.
Publicado: (2019)

Crizotinib and ceritinib trigger immunogenic cell death via on-target effects
por: Petrazzuolo, Adriana, et al.
Publicado: (2021)

Ceritinib is a novel triple negative breast cancer therapeutic agent
por: Dong, Shengli, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nnstq0cj1bbvp509bkiulgruim